🧬 Engineering a Drug Hunter: From Vet School to Big Pharma | Martin Brenner Rerelease (1/3)

Jon Chee sits down with Martin Brenner, CEO and CSO of iBio, an AI drug discovery company building immunotherapies for difficult-to-treat cancers. Before biotech leadership, Martin built one of pharma's most unconventional careers—electrical engineer in Stuttgart, vet medicine at LMU Munich, PhD embedded at Eli Lilly, youngest scientist to lead a 20-person team there. Part 1 covers his formative years: the family that shaped him, the vet clinic that changed his path, and the professor who lit the match.